Clinical trial
An Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.
NCT05018286 is registered in ClinicalTrials.gov with VectivBio AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.
- Lead sponsor
- VectivBio AG
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- July 13, 2021
- Completion date
- October 30, 2027
- Enrollment
- 158 (actual)
- Sites
- 66
Conditions
As the registry lists them; a condition with its own page is linked.